Bunkerhill AVC vs Cleerly LABS

Similar category, different focus. These tools serve overlapping but distinct needs. Comparability 65/100 Comparability is an AI-graded 0–100 score of how directly these two tools compete — higher means a more apples-to-apples comparison.
by BunkerHill Health
VS
by Cleerly

AI Verdict

Bunkerhill AVC specializes in the opportunistic detection and quantification of aortic valve, coronary, and mitral calcifications, as well as bone density, from general chest CTs, utilizing a generative AI platform for broader clinical reasoning. Cleerly LABS, conversely, offers a dedicated, AI-powered comprehensive analysis of coronary CT angiography (CCTA) to characterize coronary artery atherosclerosis, plaque, and stenosis. While both tools leverage AI for cardiovascular assessment from CT imaging, their distinct primary targets and input scan types position them as adjacent rather than direct competitors.

Choose Bunkerhill AVC if…

Choose Bunkerhill AVC if your health system aims to opportunistically screen for various calcifications, including aortic valve calcification, coronary artery calcification, and mitral annular calcification, from existing chest CT scans. This tool is ideal for integrating these findings directly into EHR workflows to enhance early detection and population health management without requiring dedicated cardiac imaging studies.

View Bunkerhill AVC →

Choose Cleerly LABS if…

Choose Cleerly LABS if you require a dedicated, comprehensive analysis of coronary CT angiography (CCTA) to precisely detect, quantify, and characterize atherosclerosis and stenosis in the coronary arteries. This tool is best suited for clinicians focused on personalized heart disease management, risk assessment, and tracking disease progression over time based on detailed plaque morphology and stenosis evaluation.

View Cleerly LABS →

Reviewed by Pouyan Golshani, MD — Interventional Radiologist

Quick Comparison

Feature Bunkerhill AVC Cleerly LABS
Pricing Contact for pricing Per analysis
Deployment Integrates with full Electronic Health Records (EHRs) and clinical archives within health systems. Cloud-based (AWS), web-based application, with on-site Cleerly Proxy for data transfer.
FDA Status 1 AI-estimated 1 AI-estimated

Head-to-Head

AI-generated assessment across six dimensions based on each tool's documented features and compliance posture. Grounded in public data — not a substitute for hands-on evaluation.

Usability

Bunkerhill AVC

Tool A, Bunkerhill's Carebricks platform, offers deep integration with EHRs and features like Carebricks Chat, which uses natural language processing for conversational interaction with a patient's entire medical history. This approach aims to provide instant context and automate next steps, significantly streamlining clinical workflows and reducing manual effort for clinicians.

Clinical Value

Cleerly LABS

While Tool A provides valuable opportunistic screening for multiple conditions, Tool B, Cleerly LABS, offers a more specialized and comprehensive analysis of coronary CT angiography (CCTA). It delivers detailed quantification and characterization of coronary plaque, stenosis, and ischemia, backed by extensive clinical evidence demonstrating superior diagnostic accuracy for personalized heart disease management and prevention.

Pricing & Value

Cleerly LABS

Tool B, Cleerly LABS, provides transparent pricing details, including a per-analysis cost and information on insurance coverage from major payers like Aetna, UnitedHealthcare, and Cigna. This clarity allows for a more straightforward assessment of its financial value. Tool A's 'contact for pricing' makes it difficult to evaluate its value proposition without direct engagement, despite having secured CMS reimbursement pathways.

Enterprise Readiness

Bunkerhill AVC

Both tools are FDA-cleared, HIPAA compliant, and have BAAs. However, Tool A's Carebricks platform emphasizes a highly configurable and adaptable system that allows health systems to design and deploy custom AI agents for a wide range of clinical and operational workflows. This deep integration with EHRs and the ability to operationalize AI ideas rapidly across the enterprise, coupled with CMS reimbursement pathways, demonstrates a more comprehensive and flexible approach to enterprise-scale AI adoption.

Innovation

Bunkerhill AVC

Tool A stands out with its 'generative AI platform, Carebricks, for clinical reasoning and action,' including customizable AI agents and natural language processing for patient record interaction (Carebricks Chat). This represents a more advanced and broadly applicable AI paradigm, moving beyond image analysis to enable dynamic, adaptable workflows and proactive care coordination.

Support & Docs

Tie

Based on the provided structured facts and web search results, there is insufficient specific information available regarding the explicit customer support channels, service level agreements (SLAs), or comprehensive public documentation for either Bunkerhill Health or Cleerly. Both companies likely offer support to their enterprise clients, but without published details, a distinction cannot be made.

Feature-by-Feature

Detail beyond the Quick Comparison summary. For pricing, deployment, BAA, FDA, and HIPAA see the Overview tab.

Feature Bunkerhill AVC Cleerly LABS
Product Name Bunkerhill AVC Cleerly LABS
Company BunkerHill Health Cleerly
Primary Focus Early detection and quantification of aortic valve calcification from chest CTs, with a generative AI platform for clinical reasoning and action. Comprehensive analysis of coronary CT angiography (CCTA) to detect, quantify, and characterize atherosclerosis and stenosis.
Key Conditions Detected/Quantified Aortic valve calcification, coronary artery calcification (iCAC, Contrast CAC), mitral annular calcification, opportunistic bone density. Coronary plaque (volume, type), stenosis, ischemia (with Cleerly ISCHEMIA module).

Videos

Demos, reviews, and walkthroughs featuring Bunkerhill AVC and Cleerly LABS.

Loading videos…
Videos need JavaScript to load. Search YouTube directly →

View all on YouTube

Frequently Asked Questions

Bunkerhill AVC specifically aids in the early detection and quantification of aortic valve calcification, coronary artery calcification, and mitral annular calcification from chest CTs, also offering opportunistic bone density assessment. Cleerly LABS focuses on comprehensive analysis of coronary CT angiography (CCTA) to detect, quantify, and characterize atherosclerosis and stenosis, and can also detect ischemia with an additional module.
Bunkerhill AVC analyzes data from chest CTs to detect various calcifications and assess bone density. Cleerly LABS is designed for comprehensive analysis of coronary CT angiography (CCTA) images.
Bunkerhill AVC integrates with full Electronic Health Records (EHRs) and clinical archives within health systems. Cleerly LABS is a cloud-based (AWS) web application that uses an on-site Cleerly Proxy for data transfer and integration with PACS, RIS, and EHR systems.
Bunkerhill AVC offers generative AI for clinical reasoning and action, customizable AI agents for diverse workflows, and natural language processing for patient record interaction via Carebricks Chat. Cleerly LABS provides 3D visualization of coronary arteries, personalized heart disease risk assessment, and the ability to track disease progression over time.
Bunkerhill AVC automates the detection and quantification of aortic valve calcification, coronary artery calcification (iCAC, Contrast CAC), and mitral annular calcification. Cleerly LABS focuses on comprehensive coronary plaque assessment (volume, type) and stenosis detection and quantification from CCTA.

Backers

Who funded each tool's parent company.

AI Tool Finder
AI-powered search. Results may not be comprehensive.